Cargando…

Whole Exome Sequencing Identifies APCDD1 and HDAC5 Genes as Potentially Cancer Predisposing in Familial Colorectal Cancer

Germline mutations in predisposition genes account for only 20% of all familial colorectal cancers (CRC) and the remaining genetic burden may be due to rare high- to moderate-penetrance germline variants that are not explored. With the aim of identifying such potential cancer-predisposing variants,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skopelitou, Diamanto, Miao, Beiping, Srivastava, Aayushi, Kumar, Abhishek, Kuswick, Magdalena, Dymerska, Dagmara, Paramasivam, Nagarajan, Schlesner, Matthias, Lubinski, Jan, Hemminki, Kari, Försti, Asta, Bandapalli, Obul Reddy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917948/ https://www.ncbi.nlm.nih.gov/pubmed/33673279 http://dx.doi.org/10.3390/ijms22041837

Ejemplares similares

Whole exome sequencing identifies novel germline variants of SLC15A4 gene as potentially cancer predisposing in familial colorectal cancer
por: Skopelitou, Diamanto, et al.
Publicado: (2022)

A Novel Low-Risk Germline Variant in the SH2 Domain of the SRC Gene Affects Multiple Pathways in Familial Colorectal Cancer
por: Skopelitou, Diamanto, et al.
Publicado: (2021)

Whole-Exome Sequencing Identifies a Novel Germline Variant in PTK7 Gene in Familial Colorectal Cancer
por: Miao, Beiping, et al.
Publicado: (2022)

Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome Sequencing
por: Srivastava, Aayushi, et al.
Publicado: (2020)

A Germline Mutation in the POT1 Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer
por: Srivastava, Aayushi, et al.
Publicado: (2020)

Whole Genome Sequencing Prioritizes CHEK2, EWSR1, and TIAM1 as Possible Predisposition Genes for Familial Non-Medullary Thyroid Cancer
por: Srivastava, Aayushi, et al.
Publicado: (2021)

Germline Variants of CYBA and TRPM4 Predispose to Familial Colorectal Cancer
por: Zhu, Lizhen, et al.
Publicado: (2022)

Cancer Predisposition Genes in Cancer-Free Families
por: Zheng, Guoqiao, et al.
Publicado: (2020)

A rare large duplication of MLH1 identified in Lynch syndrome
por: Kumar, Abhishek, et al.
Publicado: (2021)

Pedigree based DNA sequencing pipeline for germline genomes of cancer families
por: Försti, Asta, et al.
Publicado: (2016)

Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family
por: Kumar, Abhishek, et al.
Publicado: (2018)

Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK/ERK and PI3K/AKT Signaling Pathways
por: Srivastava, Aayushi, et al.
Publicado: (2019)

Combinations of Low-Frequency Genetic Variants Might Predispose to Familial Pancreatic Cancer
por: Slater, Emily P., et al.
Publicado: (2021)

Characterization of rare germline variants in familial multiple myeloma
por: Catalano, Calogerina, et al.
Publicado: (2021)

Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an example
por: Hemminki, Kari, et al.
Publicado: (2020)

Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients
por: Mahmoudpour, Seyed Hamidreza, et al.
Publicado: (2018)

Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma
por: Niazi, Yasmeen, et al.
Publicado: (2022)

Incidence, Mortality and Survival Trends in Breast Cancers Coincident with Introduction of Mammography in the Nordic Countries
por: Hemminki, Kari, et al.
Publicado: (2022)

Survival in colon and rectal cancers in Finland and Sweden through 50 years
por: Hemminki, Kari, et al.
Publicado: (2021)

Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden
por: Hemminki, Kari, et al.
Publicado: (2021)

Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment
por: Hemminki, Kari, et al.
Publicado: (2022)

Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century
por: Koskinen, Anni, et al.
Publicado: (2022)

Survival trends in hematological malignancies in the Nordic countries through 50 years
por: Hemminki, Kari, et al.
Publicado: (2022)

Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment
por: Hemminki, Kari, et al.
Publicado: (2023)

Conditional survival in breast cancer up to 10 years in the Nordic countries
por: Zitricky, Frantisek, et al.
Publicado: (2023)

Whole Exome-Trio Analysis Reveals Rare Variants Associated with Congenital Pouch Colon
por: Gupta, Sonal, et al.
Publicado: (2023)

Systematic enrichment analysis of gene expression profiling studies identifies consensus pathways implicated in colorectal cancer development
por: Lascorz, Jesús, et al.
Publicado: (2011)

Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016
por: Hemminki, Kari, et al.
Publicado: (2021)

Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden
por: Hemminki, Kari, et al.
Publicado: (2021)

Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor
por: Hemminki, Kari, et al.
Publicado: (2021)

Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years
por: Hemminki, Kari, et al.
Publicado: (2022)

Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries
por: Hemminki, Kari, et al.
Publicado: (2022)

Survival in gastric and esophageal cancers in the Nordic countries through a half century
por: Hemminki, Kari, et al.
Publicado: (2023)

Survival in Lung Cancer in the Nordic Countries Through A Half Century
por: Tichanek, Filip, et al.
Publicado: (2023)

Survival in melanoma in the nordic countries into the era of targeted and immunological therapies
por: Tichanek, Filip, et al.
Publicado: (2023)

Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century
por: Tichanek, Filip, et al.
Publicado: (2023)

Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements
por: Zitricky, Frantisek, et al.
Publicado: (2023)

Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, Marking Timing of Improvements
por: Tichanek, Filip, et al.
Publicado: (2023)

Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries
por: Tichanek, Filip, et al.
Publicado: (2023)

Incidence and survival in oral and pharyngeal cancers in Finland and Sweden through half century
por: Koskinen, Anni I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_akfjphokgmfiquf9bnmp7es8ll